Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Norfolk Southern
NSC
|
+$1.54B |
| 2 |
AT&T
T
|
+$1.35B |
| 3 |
Qorvo
QRVO
|
+$1.28B |
| 4 |
Medtronic
MDT
|
+$1.01B |
| 5 |
Digital Realty Trust
DLR
|
+$995M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.72B |
| 2 |
Apple
AAPL
|
+$1.71B |
| 3 |
Altria Group
MO
|
+$1.37B |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$904M |
| 5 |
Cheniere Energy
LNG
|
+$875M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.74% |
| 2 | Technology | 12.23% |
| 3 | Industrials | 11.76% |
| 4 | Communication Services | 9.92% |
| 5 | Consumer Discretionary | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amgen
AMGN
$222B
| $14.9B | 5.1% |
93,182,075
+15,700
| +0% | +$2.47M |
|
2
Gilead Sciences
GILD
$165B
| $9.91B | 3.39% |
100,969,260
+3,111,900
| +3% | +$316M |
|
3
Verizon
VZ
$196B
| $8.36B | 2.86% |
171,987,677
+8,675,804
| +5% | +$419M |
|
4
Amazon
AMZN
$2.96T
| $6.21B | 2.13% |
333,768,700
-14,539,200
| -4% | -$256M |
|
5
Philip Morris
PM
$295B
| $6.2B | 2.12% |
82,314,673
-6,139,845
| -7% | -$498M |
|
6
Oracle
ORCL
$423B
| $5.87B | 2.01% |
136,071,118
+3,057,000
| +2% | +$132M |
|
7
Texas Instruments
TXN
$261B
| $5.75B | 1.97% |
100,532,792
-5,989,800
| -6% | -$336M |
|
|
8
Altria Group
MO
$114B
| $5.62B | 1.92% |
112,403,603
-25,855,265
| -19% | -$1.37B |
|
9
AbbVie
ABBV
$435B
| $5.3B | 1.81% |
90,454,134
-10,098,455
| -10% | -$610M |
|
|
ALXN
10
DELISTED
Alexion Pharmaceuticals
ALXN
| $4.29B | 1.47% |
24,763,192
+473,092
| +2% | +$85.6M |
|
|
11
Alphabet (Google) Class C
GOOG
$4.32T
| $3.95B | 1.35% |
142,804,857
-138,817,560
| -49% | -$3.72B |
|
|
PCP
12
DELISTED
PRECISION CASTPARTS CORP
PCP
| $3.65B | 1.25% |
17,366,540
+3,649,314
| +27% | +$774M |
|
13
Home Depot
HD
$355B
| $3.42B | 1.17% |
30,119,821
-1,303,068
| -4% | -$144M |
|
14
General Dynamics
GD
$106B
| $3.33B | 1.14% |
24,527,872
-2,440,510
| -9% | -$335M |
|
15
Accenture
ACN
$108B
| $3.28B | 1.12% |
35,033,203
+115,000
| +0.3% | +$10.3M |
|
16
UnitedHealth
UNH
$370B
| $3.22B | 1.1% |
27,255,949
-1,474,887
| -5% | -$164M |
|
17
Netflix
NFLX
$309B
| $2.99B | 1.02% |
503,026,510
-5,755,050
| -1% | -$34.9M |
|
18
Johnson Controls International
JCI
$92.2B
| $2.92B | 1% |
55,220,553
-1,382,601
| -2% | -$70.3M |
|
|
19
AT&T
T
$163B
| $2.75B | 0.94% |
111,394,837
+53,229,121
| +92% | +$1.35B |
|
20
Crown Castle
CCI
$32.2B
| $2.69B | 0.92% |
32,551,136
+57,677
| +0.2% | +$4.91M |
|
21
Canadian Natural Resources
CNQ
$93.8B
| $2.67B | 0.91% |
180,299,134
+28,827,400
| +19% | +$412M |
|
22
CSX Corp
CSX
$93.1B
| $2.67B | 0.91% |
241,530,906
-13,707,000
| -5% | -$158M |
|
23
Union Pacific
UNP
$174B
| $2.66B | 0.91% |
24,547,262
-132,050
| -0.5% | -$15.5M |
|
24
Stryker
SYK
$130B
| $2.58B | 0.88% |
27,999,233
-1,051,900
| -4% | -$97.9M |
|
25
Baidu
BIDU
$37.2B
| $2.54B | 0.87% |
12,177,800
-35,800
| -0.3% | -$7.67M |
|
Similar funds
Capital Research Global Investors's Q1 2015 Portfolio in Review
As of Q1 2015, Capital Research Global Investors held 470 positions worth $292B, down 0.81% from $295B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Capital Research Global Investors's Q1 2015 filing shows 29 new, 129 increased, 125 reduced and 30 closed positions. Its largest new stake was Qorvo: 17,936,094 shares worth $1.43B. The largest sale was Alphabet (Google) Class C, an estimated $3.72B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.
- Capital Research Global Investors's largest Q1 2015 buy was Qorvo: 17,936,094 shares worth $1.43B.
- Capital Research Global Investors added most to Norfolk Southern in Q1 2015, an estimated $1.54B increase.
- Capital Research Global Investors's biggest Q1 2015 reduction was Alphabet (Google) Class C, cutting an estimated $3.72B.
- Capital Research Global Investors fully exited PG&E in Q1 2015, selling an estimated $596M.
- Capital Research Global Investors's ten largest holdings make up 25% of its $292B portfolio in Q1 2015.
- Capital Research Global Investors opened 29 new positions and closed 30 in Q1 2015.
- Capital Research Global Investors's portfolio value fell 0.81% quarter-over-quarter to $292B.
Based on Capital Research Global Investors's 13F filing for Q1 2015, filed 15 May 2015.